Harnessing academic excellence for biotech and drug discovery
Graeme Wilkinson, Head of Virtual R&D at Medicines Discovery Catapult, looks at how the UK can harness academic excellence to create the high quality...
Global outsourced pharma services market in 2020
Ramesh Jassal, Director and International Head of Healthcare at Clearwater International, analyses pricing pressure and how patent expiries will continue to drive strong growth...
Pharma in 2019: Has uncertainty led to pharma innovation and change?
As the year draws to a close, has uncertainty led to pharma innovation and change in 2019? Have we been in a Brexit-related stasis?...
Google or GP: Who Does the Public Trust More?
Ramya Sriram, Content and Communications Specialist at Kolabtree, looks how new research considers where the public goes for medical information and how they can...
Diversifying CSOs to provide essential services
Andy Holgate, Director of Business Development at Alveo Solutions tells all about humble beginnings, contract sales organisations and how they have diversified and grown...
How are companies adapting to engage their customers?
Clive Scragg, Director of Commercial Development at Evolve, identifies how the NHS and access to medicines renders the ‘one size fits all’ approach irrelevant,...
Myth busting remote sales solutions
Peter Hyde, Managing Director at Alveo Solutions, looks at the common myths and deciphers the reality of remote sales solutions. The industry is increasingly adopting remote...
How can CSOs optimise your sales strategy?
Mick O’ Leary, Regional President - Commercial & Patient Solutions at Ashfield Commercial & Patient Solutions looks at the advantages, challenges possible futures of...
Pf Award Winners Club 2019
Pf Award Winners past and present convened in London to celebrate their achievements and network with their peers at the Pf Award Winners Club...
ABPI complaints against sales representatives: mitigating the risk
Rina Newton, Managing Director of CompliMed, explores ABPI complaints against sales representatives and considers ways in which pharmaceutical companies could mitigate the risk of...
Latest articles
New community pharmacy quality standard highlights prevention role
A new community pharmacy quality standard published by NICE says that the teams have the potential to play a greater role in health promotion...
NICE wants more data on histology independent cancer treatments
The National Institute for Health and Care Excellence (NICE) is encouraging further data collection on ‘game changing’ histology independent cancer treatments. This comes as...
NICE approves Pfizer’s Ibrance in new combination for certain breast cancers
Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on the Cancer Drugs Fund (CDF) following Pfizer's...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Key publications to impact the UK access environment in 2020
Craig Bradley, Commercial Lead Rare GI at Takeda, PM Society Chair & PM Society Market Access Interest Group Lead, looks at key publications to...
NICE wants more data on histology independent cancer treatments
The National Institute for Health and Care Excellence (NICE) is encouraging further data collection on ‘game changing’ histology independent cancer treatments. This comes as...
Making a career move in pharma
If you feel that you have gone as far as you can in your current role, it could be time to make a career...
NICE approves Pfizer’s Ibrance in new combination for certain breast cancers
Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on the Cancer Drugs Fund (CDF) following Pfizer's...